Inoue T, Terris J, Ecelbarger C A, Chou C L, Nielsen S, Knepper M A
Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda 20892, Maryland, USA.
Am J Physiol. 1999 Apr;276(4):F559-66. doi: 10.1152/ajprenal.1999.276.4.F559.
In the renal inner medullary collecting duct (IMCD), vasopressin regulates two key transporters, namely aquaporin-2 (AQP2) and the vasopressin-regulated urea transporter (VRUT). Both are present in intracellular vesicles as well as the apical plasma membrane. Short-term regulation of AQP2 has been demonstrated to occur by vasopressin-induced trafficking of AQP2-containing vesicles to the apical plasma membrane. Here, we have carried out studies to determine whether short-term regulation of VRUT occurs by a similar process. Cell surface labeling with NHS-LC-biotin in rat IMCD suspensions revealed that vasopressin causes a dose-dependent increase in the amount of AQP2 labeled at the cell surface, whereas VRUT labeled at the cell surface did not increase in response to vasopressin. Immunoperoxidase labeling of inner medullary thin sections from Brattleboro rats treated with 1-desamino-8-D-arginine vasopressin (DDAVP) for 20 min revealed dramatic translocation of AQP2 to the apical region of the cell, with no change in the cellular distribution of VRUT. In addition, differential centrifugation of inner medullary homogenates from Brattleboro rats treated with DDAVP for 60 min revealed a marked depletion of AQP2 from the low-density membrane fraction (enriched in intracellular vesicles) but did not alter the quantity of VRUT in this fraction. Finally, AQP2-containing vesicles immunoisolated from a low-density membrane fraction from renal inner medulla did not contain immunoreactive VRUT. Thus vasopressin-mediated regulation of AQP2, but not of VRUT, depends on regulated vesicular trafficking to the plasma membrane.
在肾内髓集合管(IMCD)中,血管加压素调节两种关键转运蛋白,即水通道蛋白2(AQP2)和血管加压素调节的尿素转运蛋白(VRUT)。两者都存在于细胞内囊泡以及顶端质膜中。已证明AQP2的短期调节是通过血管加压素诱导含AQP2的囊泡运输到顶端质膜来实现的。在此,我们进行了研究以确定VRUT的短期调节是否通过类似过程发生。用NHS-LC-生物素对大鼠IMCD悬浮液进行细胞表面标记显示,血管加压素导致细胞表面标记的AQP2量呈剂量依赖性增加,而细胞表面标记的VRUT对血管加压素无反应性增加。对用1-去氨基-8-D-精氨酸血管加压素(DDAVP)处理20分钟的布拉特洛维大鼠的内髓薄切片进行免疫过氧化物酶标记显示,AQP2显著转运至细胞顶端区域,而VRUT的细胞分布没有变化。此外,对用DDAVP处理60分钟的布拉特洛维大鼠的内髓匀浆进行差速离心显示,低密度膜组分(富含细胞内囊泡)中的AQP2明显减少,但该组分中VRUT的量没有改变。最后,从肾内髓低密度膜组分中免疫分离出的含AQP2的囊泡不含免疫反应性VRUT。因此,血管加压素介导的对AQP2而非VRUT的调节取决于调节性囊泡向质膜的运输。